Title:
USES OF RECOMBINATION GANODERMA LUCIDUM IMMUNOMODULATORY PROTEIN IN SENESCENCE DELAY MEDICINES
Document Type and Number:
WIPO Patent Application WO/2016/011800
Kind Code:
A1
Abstract:
The present invention provides uses of a recombination ganoderma lucidum immunomodulatory protein (rLZ-8) in senescence delay medicines. According to the measurement of the content of the total protein, the growth hormone, the sex hormone, the thyroid hormone and the thyroid stimulating hormone in experimental animal serum, it is found that the rLZ-8 can adjust the hormone level in the senescence process, enable the hormone level to recover to normal level, and delay the senescence process of an organism.
More Like This:
| WO/2013/050590 | SPRA1 ANTIMICROBIAL PEPTIDES AND USES THEREOF |
| WO/1995/014037 | TRANSPARENT LIQUID FOR ENCAPSULATED DRUG DELIVERY |
| WO/2013/028555 | METHODS FOR WEIGHT LOSS AND KETOGENIC COMPOSITIONS |
Inventors:
ZHANG XITIAN (CN)
SUN FEI (CN)
LIANG CHONGYANG (CN)
SUN FEI (CN)
LIANG CHONGYANG (CN)
Application Number:
PCT/CN2015/071897
Publication Date:
January 28, 2016
Filing Date:
January 30, 2015
Export Citation:
Assignee:
ZHANG XITIAN (CN)
SUN FEI (CN)
SUN FEI (CN)
International Classes:
A61K38/16; A61P39/06
Foreign References:
| CN104138596A | 2014-11-12 |
Other References:
AO, HONG: "Study on Extraction, Enzymetic Hydrolysis and Antioxidation Activity of Ganoderma Lucidum Protein", SCIENCE -ENGINEERING (A), CHINA MASTER'S THESES FULL-TEXT DATABASE, 15 March 2011 (2011-03-15), pages B016 - 165
Attorney, Agent or Firm:
SANHE INTERNATIONAL IP ATTORNEYS (CN)
上海三和万国知识产权代理事务所 (CN)
上海三和万国知识产权代理事务所 (CN)
Download PDF: